Home > Search: Ranitidine Effervescent Tablets or Granules

• Search Results

Search Results Get Your Free Credit Report Right Now! Zip Code: Join our discussion forums! Providers join our directory! General Topics A-Z Conditions Treatments Medications Fitness Nutrition Anatomy Travel/Destinations Other Topics From the West From the East

Main Topic Area Ranitidine Effervescent Tablets or Granules All Topic Areas 1 - 10 of 365  more >> Ranitidine Effervescent Tablets or Granules Zantac EFFERdose Ranitidine Zantac Zantac 75 Ranitidine Bismuth Citrate Tritec Montelukast Granules Singulair Granules Ranitidine Oral Syrup Articles 1 - 1 of 1 Statement on Generic Oxycodone Hydrochloride Extended Release Tablets The Food and Drug Administration today released the following statement on its approval of generic oxycodone hydrochloride extended-release tablets: Oxycodone hydrochloride extended-release products, such as OxyContin and its generic versions, are important options for the management of moderate-to-severe chronic pain, such as that associated with cancer and various other illnesses. FDA's approval of two generic oxycodone hydrochloride products should make this safe and effective medicine... U.S. Food and Drug Administration News 1 - 5 of 188  more >> Actavis Receives Approval For Ranitidine Syrup In The U.S. MedicalNewsToday - Sat, 03 Mar 2007 08:00 EST Actavis Launches Alprazolam ER Tablets In The U.S. MedicalNewsToday - Thu, 15 Feb 2007 08:00 EST Tekturna(R) - The First New Type Of High Blood Pressure Medicine In More Than A Decade - Receives Its First Approval In The US MedicalNewsToday - Wed, 07 Mar 2007 08:00 EST Lipitor Significantly Reduced The Risk Of Serious Cardiovascular Events Compared With Simvastatin In An 80,000-Patient AnalysisManage MedicalNewsToday - Sat, 03 Mar 2007 08:00 EST Fish haters can get strong bones too Reuters - Fri, 23 Feb 2007 02:12 EST Clinical Trials 1 - 5 of 129  more >> Study of the Effectiveness and Tolerability of OROS Hydromorphone HCI SR(Slow-Release) Tablets and Immediate-Release Hydromorphone Tablets in Patients With Chronic Pain ClinicalTrials.gov Identifier: NCT00410943 - Active, not recruiting Pain PK, PD and Safety of Multiple Doses of V1512 Tablets in PD Patients Compared to Standard Levodopa/Carbidopa Oral Tablets ClinicalTrials.gov Identifier: NCT00491998 - Recruiting Parkinson's Disease Study of 3 Doses of NeoFuse Combined With MasterGraft Granules in Subjects Requiring Posterolateral Lumbar Fusion (PLF) ClinicalTrials.gov Identifier: NCT00549913 - Recruiting Degenerative Disc Disease; Spondylolisthesis; Spinal Stenosis A Pilot Randomized, Double-Blind, Placebo-Controlled, Parallel Design, Multicenter Trial to Evaluate the Effect of Ranitidine on Immunologic Indicators in Asymptomatic HIV-1 Infected Subjects With a CD4 Cell Count Between 400-700 Cells/mm3 ClinicalTrials.gov Identifier: NCT00002106 - Completed HIV Infections Budesonide Capsules vs. Mesalazine Granules vs. Placebo in Collagenous Colitis ClinicalTrials.gov Identifier: NCT00450086 - Recruiting Collagenous Colitis

GoldBambooTM Your Integrative Health and Wellness Resource December 1, 2009

email this page   |    print this page   |    bookmark this page   |    feedback on this page Page Updated: January 17, 2009

Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.